Coronavirus (COVID-19) | Omega Bio-tek

Coronavirus (COVID-19), News

FDA Authorizes New Quest Diagnostics Lab Method Designed to Increase COVID-19 Molecular Diagnostics Capacity

Posted on July 29, 2020September 10, 2020 by omega

29
Jul

Technique to increase COVID-19 molecular diagnostic testing capacity and provide faster test results reporting SECAUCUS, N.J., July 29, 2020 /PRNewswire/ — Quest Diagnostics (NYSE:DGX) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for a new laboratory technique that speeds the process of extracting viral RNA from specimens* and will enable the company to […]

Continue reading →

Coronavirus (COVID-19), Press Release

Omega Bio-tek Launches a New Viral RNA Extraction Kit for COVID-19 Testing with Production Capacity for 6 Million Tests A Month

Posted on June 8, 2020September 10, 2020 by Maevin Voigt

08
Jun

NORCROSS, GA, June 8, 2020 — Omega Bio-tek, Inc. announces the launch of the Mag-Bind® Viral RNA Xpress Kit for the rapid and reliable isolation of Viral RNA from nasopharyngeal (NP) swab specimens that are dry or in viral transport media (VTM). The new kit aims to combat the shortage of RNA purification kits, which […]

Continue reading →

Coronavirus (COVID-19), Press Release

Two Georgia Companies Unite to Provide Coronavirus (COVID-19) Testing

Posted on May 1, 2020September 10, 2020 by omega

01
May

Norcross, Ga., 05/01/2020 – Omega Bio-tek announces collaboration with Ipsum Diagnostics in the fight against COVID-19. Omega Bio-tek will supply its Mag-Bind Viral DNA/RNA 96 Kit as a vital element in Ipsum Diagnostics’ approved RT-PCR-based SARS-CoV-2 assay. The US Food and Drug Administration granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for RT-PCR-based SARS-CoV-2 testing […]

Continue reading →

Subscribe

Login

Register